NAMSA Launches Japanese Website to Support Increased Demand for Medical Device Development Services

In Asian Market, Clinical, Consulting, Press Release, Regulatory by Leah Davidson

July 17, 2017 – TOKYO, JAPAN – (BUSINESS WIRE)NAMSA, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory, clinical and consulting services is excited to announce the launch of its newly developed Japanese website.

The introduction of this highly-anticipated website is a direct result of the increased demand for NAMSA’s integrated medical device development services throughout Japan. Generating $53.2B in the medical device equipment market in 2016, Japan ranks as the world’s third largest medical product marketplace and is expected to grow steadily through 2020 (GlobalData).

“We’re extremely pleased to launch our first ever Japanese website to better serve our clients. This user-friendly and information-filled resource will not only help support our significant growth in Japan, but will also allow Japanese manufacturers to more easily identify a proven, single source solution for efficient and cost-effective medical device development,” commented Terry Tsuji, General Manager, NAMSA Japan.

NAMSA, with two Japanese office locations in Kyoto and Tokyo, provides clients with highly sought after testing, clinical and regulatory services required to accelerate medical device development and market introduction.

Medical device manufacturers seeking NAMSA’s development and market access services in Japan are encouraged to visit our regulatory webpage here, or to email NAMSA’s team of Japanese experts at japansales@namsa.com.

About NAMSA

NAMSA is a Medical Research Organization (MRO), accelerating medical device product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines – consulting, regulatory, preclinical, toxicology, microbiology, chemistry, clinical and quality – to move clients’ products through the development process, and continue to provide support through commercialization to post-market requirements anywhere in the world.

NAMSA operates 13 offices throughout North America, Europe, the Middle East and Asia, and employs nearly 1,000 highly-experienced laboratory, clinical and consulting Associates.

Follow us on Twitter, LinkedIn or Facebook for regular updates.

Authors:
Leah Davidson

Leah serves as NAMSA's Marketing Communications Manager and brings nearly 20 years of marketing communications experience within the medical device and healthcare technology industries. In her role, she is responsible for the development and implementation of brand strategies and marketing communications initiatives that help drive NAMSA’s sales and organizational growth goals globally.